Biotricity Inc.

BTCY Healthcare Medical Devices

Biotricity Inc.’s revenue for fiscal 2026 (year ended March 2026) was $16.0 million, up 16.0% from fiscal 2025.

Revenue
+10.4%
EPS
−66.7%
Free cash flow
+235.8%
Total debt
+3.48%

Quarter to June 2026, against a year earlier

0.06 0.01 +20.00%
Market cap
$10.9M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
−33.34
Beneish M
−3.24
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
9.75% 9.38% 14.19% 15.07%

+8 more TTM periods

Piotroski F-Score
6 5 4 5
ROA
(57.12%) (51.76%) (80.47%) (83.81%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
10.85% 10.00% 24.97% 26.93%
Average Days of Receivables
53.36 66.91 37.29 50.80
Free Cash Flow per Share
0.01 (0.03) (0.04) (0.02)
Free Cash Flow
0.16 (0.72) (1.10) (0.45)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026